Wissam Jaber, MD
Interventional Cardiology · Atlanta, GANPI 1053390427
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 39.9% of the total. Reporting peaked in 2022 at $79,592 and has fallen 55.5% since, to $35,398 in 2025. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $715.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$88K
- Inari Medical, Inc.$61K
- Abbott$42K
- Stryker$23K
- Intuitive Surgical$3K
- Boston Scientific$864
- plus $3K from 14 others
Across 574 payments — averaging $1329.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$396K
- Stryker$272K
- Abbott$42K
- Medtronic$32K
- EKOS Corporation$12K
- Boston Scientific$8K
- plus $225 from 1 others
What the payments were for
- Consulting fees$100,36345%
- Speaking & faculty fees$71,79532%
- Travel & lodging$36,06816%
- Food & beverage$10,5185%
- Education$3,0141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 180 | $88,421 |
| Inari Medical, Inc. | 43 | $61,447 |
| Abbott | 32 | $42,006 |
| Stryker | 16 | $23,201 |
| Intuitive Surgical | 2 | $3,017 |
| Boston Scientific | 13 | $864 |
| Shockwave Medical, Inc | 1 | $550 |
| Abiomed | 4 | $522 |
| Asahi Intecc USA, Inc. | 5 | $338 |
| Penumbra, Inc. | 3 | $324 |
| Edwards Lifesciences | 1 | $202 |
| Cordis US CORP. | 1 | $169 |
| Arrow International, Inc. | 2 | $144 |
| Heartflow, Inc. | 1 | $133 |
| Thrombolex, Inc. | 1 | $120 |
| Inquis Medical, Inc. | 1 | $114 |
| Actelion Pharmaceuticals US, Inc. | 1 | $109 |
| Ambu Inc. | 1 | $35 |
| Angiodynamics, Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$87,048
- FLOWTRIEVER CATHETER, S$76,548
- Resolute$33,562
- Xience V coronary stent system$29,117
- RESOLUTE ONYX$24,181
- DRAGONFLY OPSTAR$6,182
- OPTIS$6,000
- ONYX FRONTIER$3,125
- ION$3,000
- FlowTriever$1,466
- ClotTriever$1,324
- CLOTTRIEVER BOLD CATHETER$874
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$550
- SYMPLICITY G3$428
- Impella$425
- ROTAPRO$268
- SELUTION SLRPTA$169
- Asahi Coronary Wires$165
- Penumbra System$161
- ASAHI PTCA Guide Wire$156
How this compares
$221,758 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 167 | $196,678 |
| JardianceEmpagliflozin | 77 | $98,789 |
| FarxigaDapagliflozin Propanediol | 66 | $72,919 |
| XareltoRivaroxaban | 35 | $45,219 |
| Repatha SureclickEvolocumab | 50 | $37,813 |
| EntrestoSacubitril/Valsartan | 31 | $30,320 |
| BrilintaTicagrelor | 16 | $10,366 |
| Repatha SyringeEvolocumab | 13 | $6,804 |
| Ranolazine ErRanolazine | 33 | $4,617 |
| Atorvastatin Calcium | 250 | $2,096 |
| ClopidogrelClopidogrel Bisulfate | 220 | $2,078 |
| Metoprolol Succinate | 157 | $1,737 |
| Rosuvastatin Calcium | 135 | $1,440 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 50 | $906 |
| Prasugrel Hcl | 12 | $852 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Atlanta
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Adam GreenbaumAtlanta$238K
- Katherine KunkelAtlanta$189K
- James StewartAtlanta$174K
- Pratik SandesaraAtlanta$165K
- Chandanreddy DevireddyAtlanta$121K
- Prashant KaulAtlanta$109K
- Nikoloz ShekiladzeAtlanta$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.